Treatment News : HCV Testing, Diagnosis Being Overlooked in People With HIV - by Reed Vreeland

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » March 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


March 23, 2012

HCV Testing, Diagnosis Being Overlooked in People With HIV

by Reed Vreeland

CROI 2012Although hepatitis C virus (HCV) is a common and serious coinfection among people living with HIV, it often goes undiagnosed, even in a major U.S. city with multiple HIV care providers and a clinic dedicated to caring for people with both infections. This is the finding of a Miami cohort study reported Tuesday, March 6, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle.  

Conducted by Khaled Deeb, MD, of the University of Miami’s Miller School of Medicine and his colleagues, the analysis presented in Seattle involved a medical chart review of 14,900 people living with HIV, who were in care for more than a year during the period between 2000 and 2011.

Though HCV antibody testing is widely recommended for all people living with HIV, only 49 percent of the Miami cohort had been tested. Of this group, 19 percent were HCV-antibody positive, indicating past—but not necessarily current—HCV infection.

Forty percent of those found to be HCV-antibody positive did not have confirmatory testing, notably an HCV viral load test to look for active infection. Of the 1,074 HCV antibody-positive individuals who did receive confirmatory testing, HCV viral loads were detectable in 705 (70 percent).

Only 68 percent of those found to have active infection underwent HCV genotype testing—an important pre-treatment determination. Of those who were tested, 84 percent were living with genotype 1a HCV infection; only 11 percent carried non-1 HCV genotypes.

A majority of those living with HIV and hepatitis C were male (69 percent) and were over 50 years of age. With respect to race/ethnicity, 60 percent of people living with HIV and HCV were non-Hispanic blacks; 29 percent were Hispanic and 11 percent were white.

The authors recognized that recent improvements in HCV treatment have sparked a higher level of interest among providers and their patients. Nonetheless, Deeb noted, “only about half of the total HIV population was tested for HCV.” What’s more, he reported, “Only half of those coinfected were referred to the hepatitis C coinfection clinic.”

Deeb concluded: “There is a great need to educate providers on HCV treatment and improve care to this most vulnerable inner city population. Referring the patients to a dedicated HCV/HIV coinfection clinic may lead to better patient care and treatment outcomes.”

Search: hepatitis c, hcv, antibody, viral load, testing, diagnosis, screening, genotype, deeb, miami, croi, seattle

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.